UCSF School of Medicine

The UCSF School of Medicine strives to advance human health through a fourfold mission of education, research, patient care and public service.

https://www.ucsf.edu/

 

ASCO GU 2023 Conference Coverage
T

ASCO GU 2023 Analysis of the UNITE Study: Biomarkers of Response to Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma

By ASCO GU 2023 Conference Coverage FEATURING Tanya Jindal
By ASCO GU 2023 Conference Coverage FEATURING Tanya Jindal
103 views
March 16, 2023
Comments 0
Login to view comments. Click here to Login
Oncology & Hematology
12:19

New

A Guide for Shared Decision Making in Sickle Cell Disease

UCSF School of Medicine

M. Treadwell

13 views
08:49

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

735 views
26:22

Best of ASCO® 2024: Myeloma Highlights and Practice Impacts

UCSF School of Medicine

A. Chari

170 views
25:09

Integrative Medicine Approaches for Patients With Primary CNS Tumors

UCSF School of Medicine

N. Butowski

133 views
09:34

ASCO® 2024 Insights: "Impact of ctDNA Surveillance on Clinical Care …

2024 ASCO® Annual Meeting Insights Hub

M. Lipsyc-Sharf

299 views
09:40

Trastuzumab Deruxtecan Approval for Metastatic HER2+ Bladder Cancer

UCSF School of Medicine

V. Koshkin

262 views
36:18

Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Awar…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

1.2K views
10:09

ESMO Breast 2024 Insights: "Pooled Analysis of T-DXd Retreatment Aft…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

649 views
07:29

ESMO Breast 2024 Insights: "CAPItello-291 Trial PFS2 & TFSC Updates …

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

337 views
11:03

ESMO Breast 2024 Insights: "TROPION-Breast01 Additional Safety Analy…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

350 views
30:03

Recent Advances in Advanced Urothelial Cancers: Time for a New Stand…

UCSF School of Medicine

T. Friedlander

330 views
04:18

SABCS 2023 Insights: "Comparison of NGS Results From the Cerebrospin…

Insights from 2023 SABCS

L. Huppert

261 views
05:48

SABCS 2023 Insights: "Sequential Use of ADCs T-DXd & SG in Patients …

Insights from 2023 SABCS

L. Huppert

212 views
11:05

ASH 2023 Insights: "Alliance A051301/BMT-CTN 1201 Study - Ibrutinib …

Insights from 2023 ASH Annual Meeting

C. Andreadis

41 views
09:46

SABCS 2023 Insights: "ELEVATE Study Evaluating Elacestrant in Variou…

Insights from 2023 SABCS

H. Rugo

142 views
14:15

SABCS 2023 Insights: "KEYLYNK-009 Study - Pembro + Olaparib vs. Pemb…

Insights from 2023 SABCS

H. Rugo

321 views
08:24

SABCS 2023 Insights: "PROs From the CAPItello-291 Trial Investigatin…

Insights from 2023 SABCS

H. Rugo

606 views
19:22

SOHO 2023: BCMA/GPRC5D/FcRH5 - CARs/BsAbs - How to Choose in R/R MM

SOHO 2023 Eleventh Annual Meeting

A. Chari

150 views
22:17

IMS 2023 Insights: "Unraveling the Myeloma Proteome"

Insights from 2023 IMS Annual Meeting

A. Wiita

25 views
07:52

Independent Biomarkers Predictive of Outcomes With Enfortumab Vedoti…

ASCO GU 2023 Conference Coverage

T. Jindal

98 views
13:15

ASCO® 2023 Insights: "Biomarkers Predicting Response to 5 IO Arms in…

Insights from 2023 ASCO® Annual Meeting

D. Wolf

104 views
09:18

ASCO® 2023 Insights: "Enfortumab Vedotin +/- Pembro in Pts Who Are C…

Insights from 2023 ASCO® Annual Meeting

T. Friedlander

235 views
07:49

ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients…

ESMO Breast Cancer 2023 Congress Coverage

H. Rugo

868 views
17:44

ESMO Breast Cancer 2023 Phase 3 DESTINY-Breast04 Trial Safety Analys…

ESMO Breast Cancer 2023 Congress Coverage

H. Rugo

51 views
09:05

AACR 2023 on KEYNOTE-966 Phase 3 Study: Pembro in Combination With G…

AACR 2023 Conference Coverage

K. Kelley

352 views
06:47

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

2.1K views
03:32

Management of Abemaciclib-Related Diarrhea in HR+/HER2- eBC

UCSF School of Medicine

S. Donahue

1.1K views
05:39

ASCO GU 2023 Analysis of the UNITE Study: Biomarkers of Response to …

ASCO GU 2023 Conference Coverage

T. Jindal

103 views
10:28

IO vs. Targeted Therapy as Adjuvant Treatment in BRAFm Advanced Mela…

UCSF School of Medicine

A. Daud

347 views
08:41

ASH 2022 Long-Term Outcomes of Patients With TDT Followed Up to 8 Ye…

ASH 2022 Conference Coverage

M. Walters

98 views
11:43

CARTITUDE-1: 2 Years Post-LPI Update on the Phase 1b/2 Study of Cilt…

UCSF School of Medicine

T. Martin

222 views
47

Lecture Summary - Impact of Primary Tumor Location on OS and PFS in …

UCSF School of Medicine

A. Venook

24 views
15:07

Impact of Primary Tumor Location on OS and PFS in Patients with mCRC…

UCSF School of Medicine

A. Venook

302 views
15:00

Ongoing Clinical Trials and Future Directions in Advanced Urothelial…

UCSF School of Medicine

V. Koshkin

65 views
20:17

ESMO 2021 Updates on 1L Pembro + Chemo vs. Placebo + Chemo for mTNBC…

UCSF School of Medicine

H. Rugo

124 views
09:20

ESMO 2021 Post Hoc Analyses from PALOMA-2 and PALOMA-3: Effect of Pa…

UCSF School of Medicine

H. Rugo

310 views
05:01

ctDNA-Guided Treatment Strategy: How to Apply in Clinical Practice?

UCSF School of Medicine

A. Venook

437 views
13:13

ASCO 2021 Updates on Lisinopril or Carvedilol in Prevention of Trast…

UCSF School of Medicine

P. Munster

577 views
04:37

ASCO 2021 Update: Comparing Cilta-Cel in CARTITUDE-1 vs. Real-World …

UCSF School of Medicine

T. Martin

135 views
11:08

ASCO 2021 Updates on EV-103: Durability Results and Long-Term Outcom…

UCSF School of Medicine

T. Friedlander

450 views
15:52

ASH 2020 IKEMA Trial Update on Isatuximab in R/R MM: Should We Consi…

UCSF School of Medicine

T. Martin

201 views